Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivation.

Like Comment
A fully automated, novel high-sensitivity hepatitis B core-related antigen assay (iTACT-HBcrAg) has been developed. We demonstrate the clinical utility of iTACT-HBcrAg for monitoring chronic hepatitis B (CHB) and early detection of hepatitis B virus (HBV) reactivation.After fundamental assessments, the clinical performance of iTACT-HBcrAg was compared with other HBV markers. 1) Of our CHB patients, serial sera, available from 161 HBeAg-negative CHB patients with persistently undetectable HBV DNA, were measured by iTACT-HBcrAg and a conventional HBcrAg assay (G-HBcrAg). 2) Serial sera from 13 HBV-reactivated patients were measured by iTACT-HBcrAg and ultra-high-sensitivity hepatitis B surface antigen (HBsAg) immune complex transfer-chemiluminescent enzyme immunoassay (lower limit of detection; 0.0005 IU/mL, ICT-CLEIA) for comparison with HBV DNA detection. 3) To elucidate the various HBcrAg components iTACT-HBcrAg detected, OptiPrep density gradient centrifugation analysis was performed on sera obtained before and after HBV reactivation.The analytical performance of iTACT-HBcrAg was satisfactory. The sensitivity of iTACT-HBcrAg (2.1 Log U/mL) was approximately 10-fold greater than that of G-HBcrAg (2.8 Log U/mL). 1) HBcrAg was detectable in 97.5% (157/161) sera of CHB patients by iTACT-HBcrAg, of which 75.2% (121/161) had ≥2.8 Log U/mL HBcrAg; and 22.4% (36/161) had 2.1-2.8 Log U/mL HBcrAg, which was undetectable by G-HBcrAg. 2) Nine and 2 of 13 HBV-reactivated patients were HBcrAg-positive by iTACT-HBcrAg before and at HBV DNA positivity, respectively. Seven and 4 were HBcrAg-positive by iTACT-HBcrAg before and at being HBsAg-positive by ICT-CLEIA, respectively. 3) The HBcrAg detected before HBV reactivation by iTACT-HBcrAg was contained in empty particles (22-KDa precore protein).iTACT-HBcrAg should be of increased benefit for monitoring novel anti-HBV treatments for HBeAg-negative patients and early detection of HBV reactivation.

View the full article @ Journal of Hepatology

Get PDF with LibKey
Authors: Takako Inoue, Shigeru Kusumoto, Etsuko Iio, Shintaro Ogawa, Takanori Suzuki, Shintaro Yagi, Atsushi Kaneko, Kentaro Matsuura, Katsumi Aoyagi, Yasuhito Tanaka


The wider, wiser view for healthcare professionals. ClinOwl signposts the latest clinical content from over 100 leading medical journals.
6584 Contributions
0 Following